AKAN

Akanda Corp.
CAPPED RATING

Akanda Corp. (AKAN) is rated C- (2.0/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (D-). The rating has held at C- for 8 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.0 / 5.0
C-
Value
B-
Factor Score 3.0 / 5.0
Growth
C+
Factor Score 2.5 / 5.0
Profitability
D-
Factor Score 1.1 / 5.0
Momentum
D-
Factor Score 0.7 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -2.3
Rev Growth YoY N/A
Gross Margin -12.0%
Price Return 3M -54.5%
Price Return 12M -92.4%
Catalyst Signal 0.00
Market Cap $5.8M
TTM Revenue $662.5K
Price / Sales 8.8
ROE N/A

Historical Factor Score Progression

Held C- for 8 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 B- (3.0) C+ (2.5) D- (1.1) D- (0.7) C+ (2.6) C- (2.0)
2026-11-10 B- (3.0) C+ (2.5) D- (1.1) F (0.3) C+ (2.6) C- (1.9)
2026-11-03 B- (2.9) C+ (2.5) D- (1.0) F (0.3) C+ (2.7) C- (1.9)
2026-10-27 B- (3.0) C+ (2.5) D- (1.0) F (0.4) C+ (2.6) C- (1.9)
2026-10-20 B- (3.0) C+ (2.5) D- (1.0) D- (1.0) C+ (2.6) C- (2.0)
Page 1 of 4